INVESTED: High-Dose vs Standard-Dose Influenza Vaccine in High-Risk Cardiovascular Disease Patients

November 13-17, 2020; Virtual Conference
High-dose trivalent influenza vaccine was comparable to standard-dose quadrivalent vaccine regarding deaths or cardiopulmonary hospitalizations.
Format: Microsoft PowerPoint (.ppt)
File Size: 217 KB
Released: November 20, 2020


Provided by Clinical Care Options

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley

Supported by an educational grant from

Related Content

Vericiguat VICTORIA subgroup analysis from AHA, as reported by CCO

Released: November 18, 2020

Ferric carboxymaltose reduced risk of subsequent hospitalization in iron-deficient acute heart failure: AFFIRM-AHF data from AHA 2020, by CCO

Released: November 18, 2020

Omecamtiv mecarbil reduced time to first heart failure event or cardiovascular death in patients with heart failure with reduced ejection fraction: GALACTIC-HF data from AHA 2020 as reported by CCO

Released: November 16, 2020

Downloadable PDF resource with expert answers to FAQ on heart failure.

person default Margaret Bowers, DNP, FNP-BC person default Gregg C. Fonarow, MD person default Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, FASCP, FAzPA Released: July 24, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.